Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Rhabdomyosarcoma risk factors
Introduction
Overview
Overview
As all other childhood cancers, the particular risk factors of rhabdomyosarcoma is not exactly known; however, rhabdomyosarcoma is more prevalent among the patients with beckwith-wiedemann syndrome, li-fraumeni syndrome, Costello syndrome, and neurofibromatosis.
Risk Factors
Risk Factors
- The same as all other childhood cancers, the particular risk factors of rhabdomyosarcoma is not exactly known.[1]
- Higher incidence of rhabdomyosarcoma is reported among following individuals:[2][3][4]
- Exposure to radiation in utero
- Low socio-economic situations
- Antibiotic therapy soon after birth
- In children whose parents took recreational drugs such as cocaine and marijuana during pregnancy[5]
- Accelerated growth in uterus
- Rhabdomyosarcoma may be associated with following familial syndromes:[6][7][8]
- Higher risk of embryonal rhabdomyosarcom in uterine, bladder, and cervix in patients with DICER1 gene mutation and lung pleuropulmonary blastoma.[12][13]
References
References
- ↑ Grufferman S, Wang HH, DeLong ER, Kimm SY, Delzell ES, Falletta JM (1982). “Environmental factors in the etiology of rhabdomyosarcoma in childhood”. J Natl Cancer Inst. 68 (1): 107–13. PMID 6948120.
- ↑ Magnani C, Pastore G, Luzzatto L, Carli M, Lubrano P, Terracini B (1989). “Risk factors for soft tissue sarcomas in childhood: a case-control study”. Tumori. 75 (4): 396–400. PMID 2815346.
- ↑ Hartley AL, Birch JM, McKinney PA, Teare MD, Blair V, Carrette J; et al. (1988). “The Inter-Regional Epidemiological Study of Childhood Cancer (IRESCC): case control study of children with bone and soft tissue sarcomas”. Br J Cancer. 58 (6): 838–42. PMC 2246858. PMID 3224086.
- ↑ Ognjanovic S, Carozza SE, Chow EJ, Fox EE, Horel S, McLaughlin CC; et al. (2010). “Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype”. Br J Cancer. 102 (1): 227–31. doi:10.1038/sj.bjc.6605484. PMC 2813761. PMID 19997102.
- ↑ Grufferman S, Schwartz AG, Ruymann FB, Maurer HM (1993). “Parents’ use of cocaine and marijuana and increased risk of rhabdomyosarcoma in their children”. Cancer Causes Control. 4 (3): 217–24. PMID 8318638.
- ↑ Li FP, Fraumeni JF (1969). “Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?”. Ann Intern Med. 71 (4): 747–52. PMID 5360287.
- ↑ Hartley AL, Birch JM, Marsden HB, Harris M, Blair V (1988). “Neurofibromatosis in children with soft tissue sarcoma”. Pediatr Hematol Oncol. 5 (1): 7–16. PMID 3155239.
- ↑ DeBaun MR, Tucker MA (1998). “Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry”. J Pediatr. 132 (3 Pt 1): 398–400. PMID 9544889.
- ↑ Smith AC, Squire JA, Thorner P, Zielenska M, Shuman C, Grant R; et al. (2001). “Association of alveolar rhabdomyosarcoma with the Beckwith-Wiedemann syndrome”. Pediatr Dev Pathol. 4 (6): 550–8. PMID 11826361.
- ↑ Quezada E, Gripp KW (2007). “Costello syndrome and related disorders”. Curr Opin Pediatr. 19 (6): 636–44. doi:10.1097/MOP.0b013e3282f161dc. PMID 18025929.
- ↑ Matsui I, Tanimura M, Kobayashi N, Sawada T, Nagahara N, Akatsuka J (1993). “Neurofibromatosis type 1 and childhood cancer”. Cancer. 72 (9): 2746–54. PMID 8402499.
- ↑ Doros L, Yang J, Dehner L, Rossi CT, Skiver K, Jarzembowski JA; et al. (2012). “DICER1 mutations in embryonal rhabdomyosarcomas from children with and without familial PPB-tumor predisposition syndrome”. Pediatr Blood Cancer. 59 (3): 558–60. doi:10.1002/pbc.24020. PMC 3708486. PMID 22180160.
- ↑ Fernández-Martínez L, Villegas JA, Santamaría Í, Pitiot AS, Alvarado MG, Fernández S, Torres H, Paredes Á, Blay P, Balbín M (February 2017). “Identification of somatic and germ-line DICER1 mutations in pleuropulmonary blastoma, cystic nephroma and rhabdomyosarcoma tumors within a DICER1 syndrome pedigree”. BMC Cancer. 17 (1): 146. doi:10.1186/s12885-017-3136-5. PMC 5320664. PMID 28222777.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]